Regardless of whether they realize it, case managers have likely worked with patients who are living with Alzheimer’s disease or dementia. The diagnosis rate is relatively low. Even when a formal diagnosis is made, treatment is not necessarily offered — and for many patients, the diagnosis largely is overlooked.
As the pandemic continues, some healthcare facilities worldwide are providing acute care to patients in their homes. This is a necessity in places where the health systems have been overwhelmed. In other places, it is a way to provide care that might even be safer for certain medically stable patients.
Patients who received ICU care experience problems that need to be resolved before they are discharged. These can include delirium, debility, and dysphagia, researchers say.
Emerging data and reports suggest long-term stress and burnout among nurses has escalated since the COVID-19 pandemic began — which might contribute to increasing numbers of nurses leaving the workforce.
Cyberattacks have targeted 911 dispatchers, emergency medical services over the past year.
Juggling the work of an IRB of record and becoming a relying IRB can be challenging. But one underlying goal can keep an IRB on track with both roles: consistency.
Whether institutions are the IRB of record or the relying IRB, setting up a seamless process involves many time-consuming processes — and it can take years. One of the obstacles to an efficient IRB reliance effort is handling the technological details.
It is unlikely IRBs will see many studies with one enrolled participant (the N=1 study design), but they should be prepared for this type of protocol. The single-subject study design can be applied to chronic conditions like cystic fibrosis or to ultra-rare diseases.
One hot topic during a recent webinar on diversity in clinical trials centered around whether researchers should use race in a clinical trial. Using race as a variable is never neutral and never scientific, one expert noted.
Structural racism is a powerful construct that may influence participation in clinical research studies, panelists of a recent webinar noted.
